| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	4-PBA
				
			5-ASA
				
			5-aza-2'-deoxycytidine
				
			5-azacytidine
				
			A77 1726
				
			ALX 111
				
			APAs
				
			Anidulafungin
				
			BPTI
				
			Bivalirudin
				
				
					Urinary tract disorder: postmarketing Buscopan
				
			CGP 19835A
				
			Cancidas
				
				
					Urinary tract disorder: postmarketing Colimycin M
				
			D-penicillamine
				
			Enfuvirtide
				
			FK463
				
				
					Urinary tract disorder: postmarketing, 7.14% - 37.2% Forteo
				
			Gd-DTPA
				
			Glat copolymer
				
			Goserelin
				
				
					Urinary tract disorder: 1.28% - 3.18% Histrelin
				
				
					Urinary tract disorder: 4.7% Implanon
				
				
					Urinary tract disorder: postmarketing K779
				
				
					Urinary tract disorder: postmarketing, 5% LY146032
				
				
					Urinary tract disorder: postmarketing, uncommon, 15% - 22.4% Lisinopril
				
				
					Urinary tract disorder: postmarketing MDV3100
				
			Madopar
				
			Mersyndol
				
			NuvaRing
				
			PGE1
				
			Photofrin II
				
			Revasc
				
			SU5416
				
			Stalevo 50
				
			Triptorelin
				
			UDCA
				
			VACV
				
				
					Urinary tract disorder: very rare, postmarketing abiraterone
				
			acetaminophen
				
				
					Urinary tract disorder: postmarketing, rare aclidinium bromide
				
			acyclovir
				
			adefovir
				
				
					Urinary tract disorder: postmarketing adefovir dipivoxil
				
				
					Urinary tract disorder: postmarketing afatinib
				
			albendazole
				
				
					Urinary tract disorder: postmarketing alfuzosin
				
			aliskiren
				
			allopurinol
				
			alprazolam
				
				
					Urinary tract disorder: infrequent alvimopan
				
			amantadine
				
			ambrisentan
				
			amlodipine
				
			amlodipine besylate
				
			amoxicillin
				
			amphetamine
				
			amphotericin B
				
			amsacrine
				
			anagrelide
				
				
					Urinary tract disorder: 1-5% apixaban
				
			aprepitant
				
			aripiprazole
				
			arsenic
				
			arsenic trioxide
				
			atazanavir
				
				
					Urinary tract disorder: rare atomoxetine
				
			atovaquone
				
			avanafil
				
			axitinib
				
			baclofen
				
			betaine
				
			bexarotene
				
			bezafibrate
				
			bicalutamide
				
			boceprevir
				
			bortezomib
				
			bosentan
				
			bosutinib
				
			brinzolamide
				
			budesonide
				
			buprenorphine
				
			bupropion
				
				
					Urinary tract disorder: postmarketing busulfan
				
			cabazitaxel
				
			cabozantinib
				
			canagliflozin
				
			candesartan
				
			candesartan cilexetil
				
				
					Urinary tract disorder: postmarketing capecitabine
				
			carbamazepine
				
			carvedilol
				
				
					Urinary tract disorder: postmarketing cefaclor
				
			cefoxitin
				
			ceftaroline
				
			cefuroxime
				
			celecoxib
				
			cephalexin
				
			cetirizine
				
				
					Urinary tract disorder: very rare, postmarketing cevimeline
				
			cidofovir
				
				
					Urinary tract disorder: postmarketing cilazapril
				
				
					Urinary tract disorder: postmarketing ciprofloxacin
				
			cisplatin
				
			citalopram
				
				
					Urinary tract disorder: postmarketing, rare cladribine
				
			clarithromycin
				
				
					Urinary tract disorder: postmarketing, 0.273% - 0.578% clodronate
				
			clofarabine
				
			clomipramine
				
				
					Urethral disorder: infrequent Urinary tract disorderclonazepam
				
			clopidogrel
				
				
					Urinary tract disorder: postmarketing clozapine
				
			cobicistat
				
			codeine
				
			conivaptan
				
			copolymer 1
				
			crizotinib
				
				
					Urinary tract disorder: 0% - 4.07% cysteamine
				
			cytarabine
				
			d-telaprevir
				
				
					Urinary tract disorder: postmarketing dabigatran etexilate
				
			dabrafenib
				
			dalteparin
				
			dapagliflozin
				
			darifenacin
				
				
					Urinary tract disorder: uncommon darunavir
				
			dasatinib
				
			deferasirox
				
				
					Urinary tract disorder: postmarketing deferiprone
				
			deferoxamine
				
			degarelix
				
			delamanid
				
			deprenyl
				
			desmopressin
				
			desvenlafaxine
				
			diazepam
				
			diclofenac
				
			dihydrocodeine
				
			diltiazem
				
			docetaxel
				
			dolutegravir
				
			donepezil
				
			doxepin
				
			doxorubicin
				
				
					Urinary tract disorder: postmarketing duloxetine
				
				
					Urinary tract disorder: postmarketing efavirenz
				
			eletriptan
				
				
					Urinary tract disorder: infrequent empagliflozin
				
			emtricitabine
				
			entacapone
				
			eplerenone
				
			eribulin
				
			erlotinib
				
			ertapenem
				
			eslicarbazepine acetate
				
			esmolol
				
			estradiol
				
				
					Urethral disorder: postmarketing Urinary tract disorderethosuximide
				
			etoposide
				
			etoricoxib
				
				
					Urinary tract disorder: postmarketing etravirine
				
			everolimus
				
			exenatide
				
				
					Urinary tract disorder: postmarketing febuxostat
				
				
					Urinary tract disorder: postmarketing fentanyl
				
				
					Urinary tract disorder: postmarketing, 1% - 3% fesoterodine
				
			flucloxacillin
				
			fluconazole
				
			fluvoxamine
				
			formoterol
				
			fosamprenavir
				
			fosaprepitant
				
			fosaprepitant dimeglumine
				
			foscarnet
				
			fotemustine
				
			frovatriptan
				
			furosemide
				
			gabapentin
				
			gadobenate dimeglumine
				
			gadodiamide
				
				
					Urinary tract disorder: postmarketing gadofosveset
				
			gadoversetamide
				
			galantamine
				
				
					Urinary tract disorder: rare, infrequent ganciclovir
				
			gefitinib
				
				
					Urinary tract disorder: common, 12.8% gemcitabine
				
			gemifloxacin
				
				
					Urinary tract disorder: postmarketing glutamine
				
				
					Urinary tract disorder: 0% - 22.2% glycopyrrolate
				
			haloperidol
				
				
					Urinary tract disorder: postmarketing hydromorphone
				
			hydroxocobalamin
				
			hydroxybutyrate
				
			ibandronate
				
			ibuprofen
				
			idarubicin
				
			ifosfamide
				
				
					Urinary tract disorder: postmarketing iloperidone
				
			imatinib
				
			imipramine
				
			imiquimod
				
				
					Urinary tract disorder: postmarketing indapamide
				
			indinavir
				
			insulin detemir
				
			iodixanol
				
				
					Urinary tract disorder: very rare iohexol
				
				
					Urinary tract disorder: rare iopromide
				
				
					Urinary tract disorder: postmarketing iotrolan
				
			ipratropium bromide
				
			irbesartan
				
				
					Urinary tract disorder: postmarketing isomannide
				
			isosorbide-5-mononitrate
				
			isradipine
				
			itraconazole
				
				
					Urinary tract disorder: postmarketing ixabepilone
				
			ketorolac tromethamine
				
				
					Urinary tract disorder: postmarketing lanreotide
				
			lansoprazole
				
				
					Urinary tract disorder: postmarketing lasofoxifene
				
				
					Urethral disorder: uncommon Urinary tract disorder: rare leflunomide
				
			lenalidomide
				
				
					Urinary tract disorder: postmarketing, 6.76% lercanidipine
				
				
					Urinary tract disorder: uncommon letrozole
				
			leuprorelin acetate
				
				
					Urinary tract disorder: very common levonorgestrel
				
			liraglutide
				
				
					Urinary tract disorder: postmarketing lomitapide
				
			loperamide
				
				
					Urinary tract disorder: postmarketing lormetazepam
				
			lurasidone
				
			mannitol
				
			maprotiline
				
			maraviroc
				
			medroxyprogesterone acetate
				
			mefenamic acid
				
			melatonin
				
			meloxicam
				
				
					Urinary tract disorder: postmarketing, 0% - 1.3% melphalan
				
			memantine
				
				
					Urinary tract disorder: postmarketing methotrexate
				
			methylene blue
				
			methylphenidate
				
			midodrine
				
			milnacipran
				
				
					Urinary tract disorder: postmarketing mirabegron
				
			mirtazapine
				
				
					Urinary tract disorder: postmarketing mitotane
				
			modafinil
				
				
					Urinary tract disorder: postmarketing montelukast
				
				
					Urinary tract disorder: postmarketing morphine
				
			moxifloxacin
				
				
					Urinary tract disorder: postmarketing mycophenolate mofetil
				
			mycophenolic acid
				
			naproxen
				
				
					Urinary tract disorder: postmarketing nelarabine
				
			neostigmine
				
				
					Urinary tract disorder: postmarketing nifedipine
				
			nilotinib
				
			nilutamide
				
			ofloxacin
				
				
					Urinary tract disorder: postmarketing olanzapine
				
			olmesartan
				
			olsalazine
				
				
					Urinary tract disorder: postmarketing omeprazole
				
				
					Urinary tract disorder: postmarketing orlistat
				
			oxaliplatin
				
			oxybutynin
				
				
					Urinary tract disorder: postmarketing, 8.5% oxycodone
				
			oxymorphone
				
			paclitaxel
				
			paliperidone
				
				
					Urinary tract disorder: postmarketing palonosetron
				
			pamidronate
				
				
					Urinary tract disorder: postmarketing pantoprazole
				
				
					Urinary tract disorder: postmarketing parecoxib
				
			paricalcitol
				
			pazopanib
				
			pemetrexed
				
			perindopril
				
			pioglitazone
				
			piperacillin
				
			pixantrone
				
			pomalidomide
				
			posaconazole
				
				
					Urinary tract disorder: 1.67% - 1.99% pramipexole
				
			prasugrel
				
			pregabalin
				
				
					Urinary tract disorder: postmarketing, infrequent progesterone
				
			propafenone
				
				
					Urinary tract disorder: postmarketing prucalopride
				
				
					Urinary tract disorder: common quetiapine
				
				
					Urinary tract disorder: 1% quinapril
				
			quinidine
				
			rabeprazole
				
			radium
				
			raloxifene
				
				
					Urinary tract disorder: 2.5% raltegravir
				
				
					Urinary tract disorder: uncommon ranolazine
				
				
					Urinary tract disorder: postmarketing rapamycin
				
			rasagiline
				
			reboxetine
				
				
					Urinary tract disorder: 7.83% regorafenib
				
				
					Urinary tract disorder: 33% retigabine
				
			retinoic acid
				
			ribavirin
				
			rifampicin
				
			rifapentine
				
			rifaximin
				
			rilpivirine
				
			riluzole
				
				
					Urinary tract disorder: 1% risedronate
				
			risperidone
				
				
					Urinary tract disorder: postmarketing, 16% - 43% ritonavir
				
			rivaroxaban
				
			rivastigmine
				
				
					Urethral disorder: infrequent Urinary tract disorderropinirole
				
				
					Urethral disorderUrinary tract disorderropivacaine
				
			rufinamide
				
			salbutamol
				
			salmon calcitonin acetate
				
			saquinavir
				
			scopolamine
				
				
					Urinary tract disorder: postmarketing sertraline
				
				
					Urinary tract disorder: postmarketing sevoflurane
				
				
					Urinary tract disorder: postmarketing sildenafil
				
				
					Urinary tract disorder: postmarketing sitagliptin
				
				
					Urinary tract disorder: postmarketing sitaxsentan
				
			solifenacin
				
			sorafenib
				
				
					Urinary tract disorder: postmarketing sufentanil
				
			sugammadex
				
			sulfasalazine
				
				
					Urinary tract disorder: postmarketing sunitinib
				
				
					Urinary tract disorder: postmarketing tacrolimus
				
				
					Urinary tract disorder: postmarketing tadalafil
				
			tapentadol
				
			teduglutide
				
			tegaserod
				
			telavancin
				
			telmisartan
				
				
					Urinary tract disorder: rare temozolomide
				
			temsirolimus
				
			tenofovir
				
				
					Urinary tract disorder: postmarketing tenofovir disoproxil fumarate
				
				
					Urinary tract disorder: postmarketing tenoxicam
				
			testosterone
				
				
					Urinary tract disorder: postmarketing testosterone enanthate
				
				
					Urinary tract disorder: postmarketing testosterone propionate
				
			testosterone undecanoate
				
			tetrabenazine
				
			thalidomide
				
				
					Urinary tract disorder: postmarketing thiotepa
				
			ticagrelor
				
			tinidazole
				
			tiotropium
				
			tipranavir
				
			tizanidine
				
			tobramycin
				
			tolcapone
				
				
					Urinary tract disorder: infrequent, common tolvaptan
				
			topiramate
				
				
					Urinary tract disorder: postmarketing, 0% - 4.1% tramadol
				
				
					Urinary tract disorder: postmarketing trametinib
				
			trandolapril
				
			travoprost
				
			trimethoprim
				
			trimethoprim-sulfamethoxazole
				
			trospium chloride
				
			v 1784
				
				
					Urinary tract disorder: postmarketing valganciclovir
				
			valproate
				
			valsartan
				
			vandetanib
				
			vardenafil
				
			varenicline
				
			vincristine
				
				
					Urinary tract disorder: 7.23% vinflunine
				
			voriconazole
				
			warfarin
				
			ziconotide
				
				
					Urinary tract disorder: uncommon zidovudine
				
			ziprasidone
				
				
					Urinary tract disorder: postmarketing zoledronic acid
				
			zolmitriptan
				
				
					Urinary tract disorder: rare zolpidem
				
			zonisamide
				
			zuclopenthixol
				
			 |